MyFinsight
Home
Blog
About
Net increase
(decrease) in cash
-$10,385,065
(-18.27%↓ Y/Y)
Accrued liabilities
$558,805
(-91.49%↓ Y/Y)
Share-based compensation
expense
$408,894
(-10.59%↓ Y/Y)
Prepaid expenses and
other current assets
-$300,242
(51.64%↑ Y/Y)
Accounts payable
$76,651
(-92.65%↓ Y/Y)
Net cash used in
operating activities
-$10,385,065
(-18.27%↓ Y/Y)
Canceled cashflow
$1,344,592
Net loss
-$11,729,657
(32.84%↑ Y/Y)
Back
Back
Cash Flow
ProMIS Neurosciences Inc. (PMN)
ProMIS Neurosciences Inc. (PMN)
source: myfinsight.com